BWAY
Closed
Brainsway Ltd
12.975
-0.175 (-1.33%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.15
Day's Range: 12.805 - 13.249
Send
sign up or login to leave a comment!
When Written:
1.755
Brainsway Ltd is an Israeli medical technology company that specializes in the development and commercialization of non-invasive medical devices for the treatment of various brain disorders. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Brainsway's flagship product is the Deep Transcranial Magnetic Stimulation (dTMS) system, which uses magnetic fields to stimulate targeted areas of the brain. The dTMS system is approved for the treatment of major depressive disorder and obsessive-compulsive disorder in the United States and Europe.
In addition to its dTMS system, Brainsway also offers a range of other non-invasive brain stimulation technologies, including Theta Burst Stimulation (TBS) and Low Field Magnetic Stimulation (LFMS).
The company has partnerships with leading medical centers and research institutions around the world, and its technologies have been used in numerous clinical trials and studies. Brainsway is publicly traded on the Tel Aviv Stock Exchange and the NASDAQ stock exchange.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Brainsway's flagship product is the Deep Transcranial Magnetic Stimulation (dTMS) system, which uses magnetic fields to stimulate targeted areas of the brain. The dTMS system is approved for the treatment of major depressive disorder and obsessive-compulsive disorder in the United States and Europe.
In addition to its dTMS system, Brainsway also offers a range of other non-invasive brain stimulation technologies, including Theta Burst Stimulation (TBS) and Low Field Magnetic Stimulation (LFMS).
The company has partnerships with leading medical centers and research institutions around the world, and its technologies have been used in numerous clinical trials and studies. Brainsway is publicly traded on the Tel Aviv Stock Exchange and the NASDAQ stock exchange.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








